1 unknown, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Amphetamine Addiction: new trials by email Literature Review of Amphetamine Addiction trials Research Report on Amphetamine Addiction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction Dextromethorphan, Memantine, Dextromethorphan and memantine - Amphetamine Addiction, Pharmacotherapy | Phase 2 / Phase 3 | Unknown | National Cheng-Kung University Hospital | 120 | 2020-08-11 | 2020-12-29 |
| Cannabioids as a New Intervention for Amphetamine Dependence drug administration - Amphetamine Addiction | Phase 2 | Withdrawn | Centre hospitalier de l'Université de Montréal (CHUM) | 2016-11-01 | 2020-10-23 |
Amphetamine-Related Disorders (2) · Inflammation (1) · Nerve Degeneration (1)
Chemically-Induced Disorders (2) · Mental Disorders (2) · Substance-Related Disorders (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Dextromethorphan (1) · Memantine (1)
Centre hospitalier de l'Université de Montréal (CHUM) (1) · National Cheng-Kung University Hospital (1)
Canada (1) · Taiwan (1)
Didier Jutras-Aswad, MD, MS (1) · Tzu-Yun Wang (1)